-
N-(3-((2-Aminopyrimidin-5-yl)ethynyl)-2,4-difluorophenyl)-5-chloro-2-methoxypyridine-3-sulfonamide
-
BD007804282183470-12-295%
-
¥3939.010mg
-
4-(3-((5-(4-Nitrophenyl)furan-2-yl)methylene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic acid
-
BD630647328998-25-098%
-
¥1408.0100mg
-
2-(2-(4-(3,4-Dichlorophenyl)thiazol-2-yl)hydrazono)-3-(2-nitrophenyl)propanoic acid
-
BD630638315706-13-998%
-
¥281.05mg
-
(E)-2-Methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenyl dihydrogen phosphate
-
BD583952865783-99-998%
-
¥1038.0100mg
-
SBI 0640756
-
BD014675431821280-29-899%
-
¥9063.0100mg
-
5-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)-2-chlorobenzoic acid
-
BD764723432499-63-398+%
-
¥1005.050mg
-
3-(1H-Indazol-6-yl)-N-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine
-
BD007906281448693-69-398%
-
¥1211.05mg
-
N-(3-(2-(4-Chloro-3-fluorophenoxy)acetamido)bicyclo[1.1.1]pentan-1-yl)-5-(difluoromethyl)pyrazine-2-carboxamide
-
BD013138502143542-28-198%
-
¥
-
Adenosine 5′-(trihydrogen diphosphate), P′-anhydride with phosphorothioic acid, tetralithium salt
-
BD11272193839-89-5
-
¥1660.010mg
-
eIF4A3-IN-14
-
BD018335181402931-65-098%
-
¥
-
eIF4A3-IN-4
-
BD014566802861994-92-398%
-
¥
-
eIF4A3-IN-9
-
BD018118591402931-71-898%
-
¥
-
Quinidine sulphate
-
BD15005950-54-498+%
-
¥1820.0100g
-
(S)-3-(4-(4-(4-Bromobenzoyl)-3-(4-chlorophenyl)piperazine-1-carbonyl)-5-methyl-1H-pyrazol-1-yl)benzonitrile
-
BD011029752095486-67-099%
-
¥79378.0100mg
-
eIF4A3-IN-16
-
BD018116691402931-74-198%
-
¥
-
eIF4E-IN-5
-
BD0229630698%
-
¥
-
4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[4,5]furo[3,2-c]pyridin-5a-yl)benzonitrile
-
BD012984722098191-53-697%
-
¥
-
CR-1-31-B
-
BD013130501352914-52-398%
-
¥
-
eIF4A3-IN-17
-
BD018362271402931-75-298%
-
¥
-
2-(4-Chlorophenoxy)-N-(3-(5-(cis-3-(trifluoromethoxy)cyclobutyl)-1,3,4-oxadiazol-2-yl)bicyclo[1.1.1]pentan-1-yl)acetamide
-
BD023506682278265-85-198%
-
¥